Cart summary

You have no items in your shopping cart.

Proscillaridin A

SKU: orb2943137

Description

Proscillaridin A is a natural cardiac glycoside that potently inhibits both topoisomerase I and II with IC50 values of 30 nM and 100 nM, respectively. It is utilized in cancer research to study DNA damage mechanisms and has demonstrated cytotoxic effects in various in vitro cell line assays.

Research Area

Molecular Biology

Images & Validation

Key Properties

CAS Number466-06-8
MW530.65
Purity98.38%
FormulaC30H42O8
SMILESO[C@@]12[C@]3([C@@]([C@]4(C)C(CC3)=C[C@@H](O[C@H]5[C@H](O)[C@H](O)[C@@H](O)[C@H](C)O5)CC4)(CC[C@]1(C)[C@H](CC2)C=6C=CC(=O)OC6)[H])[H]
TargetTopoisomerase
Solubility10% DMSO+40% PEG300+5% Tween 80+45% Saline:4 mg/mL (7.54 mM);DMSO:100 mg/mL (188.45 mM)

Bioactivity

Target IC50
Topo I:30 nM |Topo II:100 nM
In Vitro
proscillaridin A, on the proliferation of breast cancer MCF-7 cells. In terms of inhibition of cell proliferation of MCF-7 cells, the compounds rank in the order proscillaridin A>digoxin>ouabain. While both digoxin and ouabain inhibited topoisomerase II catalytic activity at nanomolar concentrations (100 nM), neither agent inhibited topoisomerase I catalytic activity even at concentrations as high as 100 microM. On the other hand, proscillaridin A was a potent poison of topoisomerase I and II activity at nanomolar drug concentrations (30 nM, 100 nM, respectively), suggesting that this agent may produce its cytotoxic activity by targeting both enzymes simultaneously. These studies suggest that the stabilization of DNA-topoisomerase II complexes is closely linked to the mechanism of digoxin, ouabain and proscillaridin A cytotoxicity. The potential DNA-binding properties of the cardiac glycosides have been assessed by measuring the displacement of ethidium bromide from calf thymus DNA.

Storage & Handling

Storagestore at low temperature | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature.
Expiration Date12 months from date of receipt.
DisclaimerFor research use only

Alternative Names

Inhibitor, MCF-7, inhibit, breast, cell, cancer, Proscillaridin A, topoisomerase II, Topoisomerase, topoisomerase I

Similar Products

  • Proscillaridin A (Standard) [orb3140917]

    466-06-8

    530.65

    C30H42O8

    10 mg
  • Proscillaridin A [orb1218010]

    >98% (HPLC)

    466-06-8

    530.7

    C30H42O8

    5 mg, 10 mg, 25 mg, 1 g, 500 mg, 200 mg, 100 mg, 50 mg
Quality Guarantee

Quality Guarantee

Explore bioreagents carefree to elevate your research. All our products are rigorously tested for performance. If a product does not perform as described on its datasheet, our scientific support team will provide expert troubleshooting, a prompt replacement, or a refund. For full details, please see our Terms & Conditions and Buying Guide. Contact us at support@biorbyt.com.

Key Properties

No computed properties available.

Documents Download

Datasheet
Product Information
Download

Request a Document

Protocol Information

Proscillaridin A (orb2943137)

  • Star
  • Star
  • Star
  • Star
  • Star
  • 0.0
Based on 0 reviews

Participating in our Biorbyt product reviews program enables you to support fellow scientists by sharing your firsthand experience with our products.

Login to Submit a Review

No reviews yet

Step 1: Enter information below

(Recommended: An additional animal making an allowance for loss during the experiment)

Step 2: Enter the in vivo formulation

(This is only the calculator, not formulation. Please contact us first if there is no in vivo formulation at the solubility Section.)

% DMSO +
%+
% Tween 80 +
%

Available Sizes

Select a size below

1 mg
$ 110.00
DispatchUsually dispatched within 5-10 working days
Bulk Enquiry